H.R. 3682
Referred to CommitteeImproving Transparency to Lower Drug Costs Act of 2021
Latest Action
Referred to the Subcommittee on Health.
6/2/2021 • House
Summary
Improving Transparency to Lower Drug Costs Act of 2021
This bill requires the Centers for Medicare & Medicaid Services (CMS) to publish certain payment information regarding pharmacy benefit managers (PBMs) and prescription drugs. Specifically, the CMS must publish certain information, as reported by PBMs, relating to generic dispensing rates, drug discounts and rebates, and payments between PBMs, health plans, and pharmacies, in accordance with specified confidentiality requirements.
Introduced in House • 6/1/2021
Topics & Subjects
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (3)
Party Breakdown
Sponsor
Cosponsors (2)
Bill Journey
Originated in the House
Introduced
June 1, 2021
Referred to the Subcommittee on Health.
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law